This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT. (May 2022)
Record Type:
Journal Article
Title:
MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT. (May 2022)
Main Title:
MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT